IMMR.NASDAQImmersion CORP

DEF 14A: Immersion Corporation Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

Sentiment:

Proxy Statement


Immersion Corporation's 2024 Annual Meeting of Stockholders will address director elections, auditor ratification, executive compensation, and an amendment for officer exculpation.

Summary

  • Immersion Corporation will hold its Annual Meeting of Stockholders on April 29, 2024, at 10:00 a.m. Eastern Time, at the offices of Olshan Frome Wolosky LLP in New York.
  • Stockholders of record as of March 27, 2024, are eligible to vote.
  • The meeting will address the election of five directors, ratification of Plante & Moran, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, an advisory vote on executive compensation, and approval of an amendment to the company's certificate of incorporation regarding officer exculpation.
  • The Board of Directors recommends voting FOR all director nominees, FOR the ratification of the accounting firm, FOR the advisory vote on executive compensation, and FOR the adoption of the Exculpation Amendment.
  • The proxy statement and annual report are available online at www.envisionreports.com/IMMR.
  • The company may switch to a virtual meeting if an in-person meeting is not possible or advisable, with details to be announced via SEC filings and on the website.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The Board's recommendations are positive, but the overall sentiment is balanced.

Positives

  • The Board is actively engaged in corporate governance and risk management.
  • The company has established stock ownership guidelines to align the interests of directors and executives with those of stockholders.
  • The Board is recommending an amendment to exculpate officers, which they believe will attract and retain experienced officer candidates.
  • The company provides multiple avenues for stockholders to communicate with the Board.

Negatives

  • The company incurred significant fees related to changing its independent registered public accounting firm, dismissing Armanino LLP and appointing Plante & Moran, PLLC.
  • The company's executive compensation includes elements that may not be fully deductible due to Section 162(m) of the Internal Revenue Code.

Risks

  • The company faces the risk of potential litigation and insurance costs associated with lawsuits, which the officer exculpation amendment aims to mitigate.
  • The company's success depends on attracting and retaining qualified directors and executive officers, which could be impacted by factors such as personal liability concerns.
  • The company's financial performance and stock price can significantly impact the level of compensation actually paid to NEOs.

Future Outlook

The company intends to continue to review and update its corporate governance practices and compensation programs to align with best practices and stockholder interests.

Management Comments

  • Eric Singer, President, Chief Executive Officer and Chairman of the Board, expressed appreciation for stockholders' continued support and interest in the company.
  • The Board believes that adopting the Exculpation Amendment is in the best interests of the Company and its stockholders.

Industry Context

Many peer companies have adopted exculpation clauses that limit the personal liability of officers in their respective certificates of incorporation.

Comparison to Industry Standards

  • The company's director compensation structure, including cash retainers and equity awards, is generally consistent with industry practices for similarly sized public companies.
  • The company's risk management framework and corporate governance practices align with those of other publicly traded companies.
  • The proposed officer exculpation amendment is in line with recent changes in Delaware law and the practices of many peer companies.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President, Chief Executive Officer, and ChairmanFrancis JoseEric SingerJanuary 3, 2023Appointment
Chief Financial Officer and TreasurerAaron AkermanJ. Michael DodsonJune 12, 2023Appointment

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Certificate of IncorporationTo provide for exculpation of certain officers of the Company as permitted by recent amendments to Delaware law.Upon filing with the Secretary of State of the State of DelawareThe Board believes that adopting the Exculpation Amendment is in the best interests of the Company and its stockholders.

Stakeholder Impact

  • Approval of the director nominees will ensure continued oversight of the company's strategy and operations.
  • Ratification of the independent auditor will provide assurance of the company's financial reporting.
  • The advisory vote on executive compensation allows stockholders to express their views on the company's pay practices.
  • Approval of the officer exculpation amendment could impact the company's ability to attract and retain qualified officers.

Next Steps

  • Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
  • The company will file the amendment to the Charter with the Secretary of State of the State of Delaware if Proposal 4 is approved.
  • The Board will consider the outcome of the advisory vote on executive compensation when making future compensation decisions.

Key Dates

DateDescription
June 5, 2017The Amended and Restated Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware.
August 16, 2022Audit Committee dismissed Armanino LLP as independent registered public accounting firm and appointed Plante Moran.
March 30, 20232023 Annual Meeting of Stockholders.
March 27, 2024Record date for stockholders eligible to vote at the Annual Meeting.
April 4, 2024Date of the letter to stockholders and notice of the Annual Meeting.
April 5, 2024Approximate date proxy materials will be mailed to stockholders.
April 29, 2024Date of the Annual Meeting of Stockholders.
December 5, 2024Deadline for stockholder proposals not to be included in the proxy statement for the 2025 Annual Meeting.
December 6, 2024Deadline for stockholder proposals to be included in the proxy statement for the 2025 Annual Meeting.
December 5, 2024 January 4, 2025Window for stockholder nominations for director candidates for the 2025 Annual Meeting.
February 28, 2025Deadline for stockholders intending to solicit proxies in support of director nominees other than the Company's nominees to provide notice.

Keywords

Annual Meeting, Proxy Statement, Directors, Executive Compensation, Officer Exculpation, Corporate Governance, Stockholders, Plante & Moran, Immersion Corporation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.